Douglas Orr

1.9k citations
21 papers · 1.6k · 1 hit paper · h-index 11

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • CAR-T cell therapy research 4
    • HER2/EGFR in Cancer Research 4
    • Immunotherapy and Immune Responses 4
    • Immune Cell Function and Interaction 4

Douglas Orr

19 papers receiving 1.5k citations

Douglas Orr's Hit Papers

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer 1987 · 1.0k citations
1.0k0+13+26Years since publication2505007501000

Peers

Douglas Orr
Comparison fields: 5 of 92
  • Immunology 755
  • Oncology 631
  • Hepatology 104
  • Hematology 98
  • Biotechnology 63
Replace Ulf Petrausch with:
Ulf Petrausch Switzerland
Satoshi Wada Japan
Masaki Tomita Japan
Patricia Della Pelle United States
Inês Pires da Silva Australia
Jie Deng China
Masahiro Ohira Japan
Tsvetelina Pentcheva‐Hoang United States
Yongli Shuai United States
Douglas Orr relative to Ulf Petrausch Switzerland Ulf Petrausch's profile →
Citations per field
00.5×3.2×
Ulf Petrausch · 1×
Citations per year

Countries citing papers authored by Douglas Orr

Since Specialization
Citations

This map shows the geographic impact of Douglas Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Orr more than expected).

Fields of papers citing papers by Douglas Orr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Orr. The network helps show where Douglas Orr may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas Orr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas Orr Line = papers co-authored together Douglas Orr links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
Hit paper breakdown →
19871032
2 2008170
3 1991101
4 200353
5 201443
6 200638
7
Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
199933
8
Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro.
199017
9
Adriamycin custom-tailored immunoconjugates in the treatment of human malignancies.
198817
10 198814
11 200311
12 200810
13 19999
14 19897
15 20236
16
Phase I trial of mitomycin C immunoconjugates cocktails in human malignancies.
19896
17 19885
18 20243
19 20002
20 20250

About Douglas Orr

Douglas Orr is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Hepatitis B Virus Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (755 citations), Oncology (631 citations), Hepatology (104 citations), Hematology (98 citations) and Biotechnology (63 citations). Douglas Orr has collaborated with scholars based in United States, Germany and New Zealand. Frequent co-authors include Kurt W. Tauer, John R. Yannelli, Gailen D. Marshall, Robert K. Oldham, Gary B. Thurman, William H. West, Robert M. Goldstein, Jane Dempster, Gary L. Davis and Mark W. Walberg. Their work appears in journals such as Journal of Clinical Oncology, Transplantation, Journal of Hepatology, New England Journal of Medicine and The International Journal of Biological Markers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact